临床试验/TCTR20240812005

TCTR20240812005已完成3 期

Hemostatic Changes Following COVID-19 Vaccination

Faculty of Medicine Siriraj Hospital0 个研究点目标入组 195 人开始时间: 2024年8月12日最近更新: 2024年8月19日

试验速览

阶段: 3 期
状态: 已完成
发起方: Faculty of Medicine Siriraj Hospital
入组人数: 195

研究概览入排标准研究者记录与标识符相似试验

研究概览

简要总结

o d-dimer changes in d-dimer post COVID-Vaacination

研究设计

研究类型: Interventional

入排标准

年龄范围: 18 Years 至 N/A (No limit)（—）
性别: All

入选标准

•Healthy participants aged 18 years or older who received COVID-19 vaccines, including the ChAdOx1-S and BNT162b2 vaccines.

排除标准

•pregnant women, history of arterial or venous thrombotic events, participants treated with anticoagulants/antiplatelet therapy, ongoing cancer treatment, thrombocytopenia, and initial D-dimer elevation

研究者

发起方

Faculty of Medicine Siriraj Hospital

相似试验

Hemostatic changes after COVID-19 vaccination in patients with hematologic malignancy diseasesCancer patients are considered to be at higher risk of thrombosis than the normal population. As previously reported, thromboembolic complications are five times more common among cancer patients than the normal population, with up to 10-15% during the incurable period. Patients with hematologic malignancies also have an increased risk of thromboembolic complications.Hemostatic changes after COVID-19 vaccination in patients with hematologic malignancy diseases

TCTR20211109005Siriraj Hospital Mahidol University400

进行中（未招募）

COVID-19 Post-Vaccination ObservationImmune System DiseasesCOVID-19 Vaccine Adverse ReactionImmune System Disorder

NCT06107348Yang I. Pachankis, PhD1

Impact of COVID-19 Vaccination on Serum 25-hydroxyvitamin D LevelAcne VulgarisVitamin D DeficiencyCOVID-19

NCT05398939National Taiwan University Hospital20

Immune response to COVID-19 vaccination in hemato-oncology patientshematooncological diseases

DRKS00027372Krukenberg Krebszentrum Halle398

Hemostasis in COVID-19: an Adaptive Clinical TrialCOVID-19

NCT04466670University of Sao Paulo General Hospital379